Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Surrozen, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 3 Li Yang (Exec. Vice President, Research) has filed a Form 3 on Surrozen, Inc./DE
05/19/2023 4 Lin Shao-Lee (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 WOODHOUSE DAVID J (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 Rothenberg Mace (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 Kutzkey Tim (10% Owner) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 CHAI CHRISTOPHER Y (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 Haak-Frendscho Mary (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/19/2023 4 BJERKHOLT ERIC (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
04/05/2023 3 BJERKHOLT ERIC (Director) has filed a Form 3 on Surrozen, Inc./DE
03/02/2023 4 Parker Craig C (CEO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 405,000 options to buy @ $1.13, valued at $457.7k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Parker Craig C (CEO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 9,578 shares @ $0.41, valued at $3.9k
12/19/2022 4 Vanhove Geertrui (Chief Medical Officer) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 9,578 shares @ $0.41, valued at $3.9k
12/19/2022 4 Williams Charles O (CFO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 9,578 shares @ $0.41, valued at $3.9k
12/15/2022 4 BLUTT MITCHELL J MD (10% Owner) has filed a Form 4 on Surrozen, Inc./DE
Txns: Sold 1,748,750 shares @ $0
Sold 1,297,922 shares @ $0
Sold 450,827 shares @ $0
Sold 1,885,000 shares @ $0
Sold 582,916 warrants @ $11.5, valued at $6.7M
Sold 432,639 warrants @ $11.5, valued at $5M
Sold 150,275 warrants @ $11.5, valued at $1.7M
Sold 144,666 warrants @ $11.5, valued at $1.7M
10/13/2022 4 Vanhove Geertrui (Chief Medical Officer) has filed a Form 4 on Surrozen, Inc./DE
Txns: Disposed/sold 24,587 options to buy @ $10.77, valued at $264.8k
Disposed/sold 10,427 options to buy @ $10.25, valued at $106.9k
Disposed/sold 26,220 options to buy @ $10.25, valued at $268.8k
Disposed/sold 1,760 options to buy @ $10.77, valued at $19k
Granted 26,220 options to buy @ $2.16, valued at $56.6k
Granted 10,427 options to buy @ $2.16, valued at $22.5k
Granted 24,587 options to buy @ $2.16, valued at $53.1k
Granted 1,760 options to buy @ $2.16, valued at $3.8k
10/13/2022 4 Williams Charles O (CFO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Disposed/sold 77,972 options to buy @ $5.13, valued at $400k
Disposed/sold 2,433 options to buy @ $10.25, valued at $24.9k
Disposed/sold 12,164 options to buy @ $10.25, valued at $124.7k
Disposed/sold 97,676 options to buy @ $5.13, valued at $501.1k
Granted 12,164 options to buy @ $2.16, valued at $26.3k
Granted 97,676 options to buy @ $2.16, valued at $211k
Granted 2,433 options to buy @ $2.16, valued at $5.3k
Granted 77,972 options to buy @ $2.16, valued at $168.4k
10/12/2022 4 Yeh Wen-Chen (Chief Scientific Officer) has filed a Form 4 on Surrozen, Inc./DE
Txns: Disposed/sold 29,567 options to buy @ $10.77, valued at $318.4k
Disposed/sold 5,562 options to buy @ $10.77, valued at $59.9k
Granted 500 options to buy @ $3.15, valued at $1.6k
Granted 5,562 options to buy @ $2.16, valued at $12k
Granted 29,567 options to buy @ $2.16, valued at $63.9k
10/12/2022 4 Parker Craig C (CEO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Disposed/sold 35,987 options to buy @ $10.77, valued at $387.6k
Disposed/sold 2,065 options to buy @ $10.25, valued at $21.2k
Disposed/sold 181,270 options to buy @ $10.25, valued at $1.9M
Disposed/sold 315,310 options to buy @ $10.77, valued at $3.4M
Granted 35,987 options to buy @ $2.16, valued at $77.7k
Granted 315,310 options to buy @ $2.16, valued at $681.1k
Granted 181,270 options to buy @ $2.16, valued at $391.5k
Granted 2,065 options to buy @ $2.16, valued at $4.5k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Rothenberg Mace (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $2.79, valued at $55.8k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Yeh Wen-Chen (Chief Scientific Officer) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 125,000 options to buy @ $3.11, valued at $388.8k
03/03/2022 4 Parker Craig C (CEO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 370,000 options to buy @ $3.11, valued at $1.2M
03/03/2022 4 Williams Charles O (CFO) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 125,000 options to buy @ $3.11, valued at $388.8k
03/03/2022 4 Vanhove Geertrui (Chief Medical Officer) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 125,000 options to buy @ $3.11, valued at $388.8k
08/20/2021 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
08/20/2021 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy